...
首页> 外文期刊>BMJ quality & safety >Improving rates of ferrous sulfate prescription for suspected iron deficiency anaemia in infants
【24h】

Improving rates of ferrous sulfate prescription for suspected iron deficiency anaemia in infants

机译:提高患有婴幼儿缺乏缺铁性贫血的硫酸亚铁处方的速率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Iron deficiency anaemia (IDA) in infancy is prevalent and associated with impaired neurodevelopment; however, studies suggest that treatment and follow-up rates are poor. Objectives To improve the rate of ferrous sulfate prescription for suspected IDA among infants aged 8-13 months to 75% or greater within 24 months. Methods We implemented a multidisciplinary process improvement effort aimed at standardising treatment for suspected IDA at two academic paediatric primary care clinics. We developed a clinical pathway with screening and treatment recommendations, followed by multiple plan-do-study-act cycles including provider education, targeted reminders when ferrous sulfate was not prescribed and development of standardised procedures for responding to abnormal lab values. We tracked prescription and screening rates using statistical process control charts. In post hoc analyses, we examined rates of haemoglobin (Hgb) recheck and normalisation for the preintervention versus postintervention groups. Results The prescription rate for suspected IDA increased from 41% to 78% following implementation of the intervention. Common reasons for treatment failure included prescription of a multivitamin instead of ferrous sulfate, and Hgb not flagged as low by the electronic medical record. Screening rates remained stable at 89%. Forty-one per cent of patients with anaemia in the preintervention group had their Hgb rechecked within 6 months, compared with 56% in the postintervention group (p<0.001). Furthermore, 30% of patients with anaemia in the postintervention group had normalised their Hgb by 6 months, compared with 20% in the preintervention group (p<0.05). Conclusions A multipronged interdisciplinary quality improvement intervention enabled: (1) development of standardised practices for treating suspected IDA among infants aged 8-13 months, (2) improvement of prescription rates and (3) maintenance of high screening rates. Rates of Hgb recheck and normalisation also increased in the intervention period.
机译:背景技术缺铁性缺乏症(IDA)普遍存在,具有神经发育受损的损伤;然而,研究表明,治疗和后续税率差。目的,提高患有8-13个月婴儿婴儿的硫酸含铁率的含量处方率为24个月内的75%或更高。方法我们实施了多学科的过程改进努力,旨在在两位学术儿科初级保健诊所进行标准化疑似IDA的治疗。我们开发了一种临床途径,具有筛选和治疗建议,其次是多个计划实践行为的循环,包括提供者教育,当没有规定硫酸亚铁的含铁股份时,有针对性的提醒,用于应对异常实验室值的标准化程序。我们使用统计过程控制图跟踪处方和筛选率。在后HOC分析中,我们检查了血红蛋白(HGB)重新认证和正常化的血红蛋白(HGB)的率。结果执行干预后,可疑IDA的处方率从41%增加到78%。治疗失败的常见原因包括多种维生素的处方代替硫酸亚铁,HGB没有由电子医疗记录标记为低。筛选率保持稳定为89%。预领取群体中的40%患有贫血患者的HGB在6个月内重新检查,而在后勤组织中为56%(P <0.001)。此外,30%的患有后勤组贫血患者将其HGB标准化为6个月,而在预领取基团中为20%(P <0.05)。结论使多元互学科质量改善干预措施:(1)在8-13个月婴儿治疗婴儿的涉嫌IDA的标准化实践的制定,(2)改善处方率和(3)高筛选率的维护。 HGB重新检查和标准化的率也在干预期内增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号